Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
10/2003
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003CN1452630A Substd. sapogenins and their use
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451401A External applied plaster for treating fracture and injury
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638767 Methods for delivering compounds into a cell
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087083A1 5-alkyl-7-alkylcarbonate-isoflavone ester as isoflavone prodrug
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086417A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003051315A3 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/23/2003WO2003048773A3 Methods for monitoring amyotrophic lateral sclerosis
10/23/2003WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199546 6-(((2S)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199506 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353671A1 Neurotrophic tacrolimus analogs
10/22/2003EP1353664A2 Heterocycle derivatives and methods of use for treating anthrax infection
10/22/2003EP1084122B1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/22/2003EP1003749B1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1450908A Neurotoxic oligomers
10/22/2003CN1450904A Use of ribose to prevent cramping and soreness in muscles
10/22/2003CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084565A2 Ve-ptp as regulator of ve-cadherin mediated processes or disorders
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084351A1 Use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003051393A3 Enzymatic cleavable reagents for specific delivery to disease sites
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002036151A3 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
10/16/2003WO2002036118A3 Heterocyclic derivatives useful as pharmaceutical agents
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 233